MICA · CARE LEARNING NOTES
Observe, keep care safe and communicate
The subcutaneous route involves products with different requirements. Checking the medicine and its device is as important as selecting an appropriate site and monitoring tolerance.
Identify product and device
Check identity, prescription, medicine, concentration, presentation and authorised route. An insulin pen and a prefilled syringe for another treatment are not interchangeable. Read the instructions for the actual product available; similar packaging does not establish equivalence. Resolve any discrepancy between prescription, label and equipment before care with the prescriber or pharmacist. This guide does not provide dose calculations.
[1][2]Prevent contamination
Prepare care in a clean area, limiting interruptions and maintaining hand hygiene. Single-use equipment must not be reused. An insulin pen remains dedicated to the same patient even when the needle is changed because its contents can be contaminated. Check dates, storage conditions and time limits after opening against the product instructions.
[1][2]Assess the site without improvising
Before administration, look for painful, inflamed, bruised or indurated areas and ask the patient about previous difficulties. The site and any rotation requirements depend on the product and care plan. Recommendations for one medicine must not automatically be transferred to another. A trained, authorised professional performs the procedure within the prescription and applicable protocol.
[1][2]For insulin, distinguish the patient-dedicated device from single-use supplies. Pens must never be shared, even after changing the needle. Prepare the dose in a clean area, using a new needle and syringe when this equipment is used. Never reuse a syringe between patients. Any treatment adjustment must remain within the prescribed plan.
- Check the exact insulin name and concentration before each administration.
Monitor and hand over
Distinguish a limited local reaction from deterioration requiring assessment: unusual pain, progressive swelling, persistent bleeding or systemic signs. With insulin, glucose monitoring and instructions for symptoms must be explicit in the treatment plan. After care, dispose of sharps immediately in the appropriate container. Record the administered product, site, time and any abnormality without dismissing a possible error.
[1][2]A learning situation
FICTIONAL SITUATION · REFLECTION WITHOUT A SCORE
Fictional situation: two patients are prescribed the same insulin. A previously used pen is offered for the second patient with a new needle.
Does changing the needle make this acceptable?
Read the reasoning
No. The pen must not be shared even with a new needle. Obtain a device dedicated to the patient and report the situation. If cross-use has already occurred, initiate the institutional exposure assessment and associated documentation. Prevention relies on individual device identification and storage that avoids mix-ups.
References and scope
- Preventing Unsafe Injection Practices ↗
- Considerations for Blood Glucose Monitoring and Insulin Administration ↗
Original documentary teaching summary for adult care. Procedures and medicines depend on professional competence, prescription and institutional procedures. International references do not establish an Algerian protocol. Independent human scientific review remains to be confirmed.